Search results for "FAT"

showing 10 items of 4644 documents

Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis

1998

Asthma and chronic bronchitis are inflammatory diseases with extracellular matrix (ECM) remodeling and collagen deposition. Collagen homeostasis is controlled by metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). We evaluated MMP and TIMP balance in induced sputum of 10 control, 31 untreated asthmatic, and 16 chronic bronchitic subjects. We first performed zymographic analysis to identify the profile of MMPs. Zymography revealed a similar MMPs profile in all populations studied and that MMP-9 was the major enzyme released. We then measured, using enzyme immunoassay, the concentrations of MMP-9 and of its inhibitor TIMP-1 and evaluated whether airflow limitation m…

AdultPulmonary and Respiratory MedicineChronic bronchitisAdolescentNeutrophilsCell CountEnzyme-Linked Immunosorbent AssayMatrix metalloproteinaseCritical Care and Intensive Care MedicinePathogenesisLeukocyte CountSurface-Active AgentsForced Expiratory VolumemedicineHomeostasisHumansProtease InhibitorsCollagenasesBronchitisAgedAsthmaTissue Inhibitor of Metalloproteinase-1business.industryMacrophagesRespiratory diseaseSputumSodium Dodecyl SulfateMiddle AgedTissue inhibitor of metalloproteinasemedicine.diseaseAsthmaExtracellular Matrixrespiratory tract diseasesAirway ObstructionMatrix Metalloproteinase 9Chronic DiseaseImmunologyBronchitisSputumElectrophoresis Polyacrylamide GelCollagenmedicine.symptomPulmonary Ventilationbusiness
researchProduct

Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey

2013

WOS: 000335253700001

AdultQuality of lifemedicine.medical_specialtyActivities of daily livingInternationalityAdolescentDiseaseShort staturechemistry.chemical_compoundWheelchairQuality of lifeElosulfase alfaMedicineHumansGenetics(clinical)Pharmacology (medical)ChildGenetics (clinical)FatigueMobilityMedicine(all)Pain measurementPatient-reported outcomesbusiness.industryData CollectionResearchMucopolysaccharidosis IVGeneral MedicineGaithumanitiesEQ-5D-5LchemistryWheelchairsJoint painPhysical therapymedicine.symptombusinessMorquio A syndromeOrphanet Journal of Rare Diseases
researchProduct

Ultrastructure of the Retina in Adult Neuronal Ceroid Lipofuscinosis

1998

A 33-year-old woman died of biopsy-proven adult neuronal ceroid lipofuscinosis (NCL) or Kufs’ disease marked by fingerprint and curvilinear lipopigments in neural and nonneural cell types. She had never experienced visual impairment or shown electroretinographic abnormalities. At autopsy, her retina appeared intact without degeneration at the light-microscopic level, but nerve cells in different layers were loaded with lipopigments of the granular type. This appears to be the third ultrastructural study of the retina in a patient with adult NCL, a former one showing preservation of the retina, another retinal degeneration. Thus, only further molecular genetic data will clarify the nosology …

AdultRetinal Ganglion CellsRetinal degenerationCell typePathologymedicine.medical_specialtyHistologyAutopsyDegeneration (medical)BiologyRetinaAdult neuronal ceroid lipofuscinosisFatal OutcomeNeuronal Ceroid-LipofuscinosesmedicineHumansKufs diseaseRetinaPigments BiologicalAnatomymedicine.diseaseLipidsMicroscopy Electronmedicine.anatomical_structureUltrastructureFemaleAnatomyCells Tissues Organs
researchProduct

Carbohydrate ingestion does not influence the change in energy cost during a 2-h run in well-trained triathletes

1999

The aim of this study was to examine whether the increase in the energy cost of running (C(r)), previously reported to occur at the end of a prolonged run, could be influenced by the ingestion of either an artificially sweetened placebo (Pl) or a 5.5% carbohydrate (CHO) solution. Ten well-trained triathletes completed three testing sessions within a 3-week period. The aim of the first session was to determine maximal oxygen uptake (VO(2)(max)) and the velocity associated with ventilatory threshold (nu(VT)). The second and the third sessions were composed of two submaximal treadmill runs (20 min long, 0% grade, performed at nu(VT)), before and after an 80-min overground run, also conducted a…

AdultTime FactorsPhysiologyCarbohydrates[SHS.SPORT.PS]Humanities and Social Sciences/Sport/Sport physiologyAdministration OralDifferential ThresholdEnergy cost of running030204 cardiovascular system & hematologyPlaceboTriathlon[ SHS.SPORT ] Humanities and Social Sciences/SportRunning03 medical and health sciences0302 clinical medicineAnimal scienceOxygen ConsumptionRespirationIngestionHumansTreadmillRespiratory exchange ratioComputingMilieux_MISCELLANEOUSFatigue[SHS.SPORT]Humanities and Social Sciences/SportPhysical Education and TrainingChemistryRespirationPublic Health Environmental and Occupational Health[ SHS.SPORT.PS ] Humanities and Social Sciences/Sport/Sport physiologyVO2 max030229 sport sciencesSolutionsCarbohydrate feedingBreathingPhysical EnduranceVentilatory thresholdEnergy MetabolismSports
researchProduct

Accuracy of the water-siphon test associated to barium study in a high prevalence gastro-oesophageal reflux disease population: a novel statistical a…

2010

Abstract RATIONALE, AIMS AND OBJECTIVES: Gastro-oesophageal reflux disease (GORD) is 'a condition which develops when the reflux of gastric content causes troublesome symptoms or complications'. Instrumental diagnostic tests generally used for GORD are 24-hour pH-metry and upper gastrointestinal (GI) endoscopy but barium study associated with provocative manoeuvres such as the water-siphon test (WST), has also been used for GORD. The aim of this paper was to estimate the accuracy of several tests in patients with GORD in a tertiary care setting, focusing on WST, which is rapid and non-invasive, simple to perform and well-tolerated by patients. METHOD: A total of 172 consecutive patients, sy…

AdultYoung AdultDiagnostic Techniques Digestive SystemData Interpretation StatisticalGastroesophageal Refluxbarium study gastro-oesophageal reflux disease latent class analysis pH-metry water-siphon testHumansReproducibility of ResultsWaterBarium SulfateMiddle AgedAged
researchProduct

Low-Carbohydrate High-Fat Diet and Exercise: Effect of a 10-Week Intervention on Body Composition and CVD Risk Factors in Overweight and Obese Women—…

2020

We assessed the effect of weight-loss induced with a low-carbohydrate-high-fat diet with and without exercise, on body-composition, cardiorespiratory fitness and cardiovascular risk factors. A total of 57 overweight and obese women (age 40 &plusmn

Adultcardiovascular riskNormal diet030209 endocrinology & metabolismlcsh:TX341-641lean body mass030204 cardiovascular system & hematologyOverweightDiet High-FatArticleFat masslaw.invention03 medical and health sciencesDiet Carbohydrate-Restricted0302 clinical medicineAnimal scienceRandomized controlled triallawRisk Factorsdietary interventionmedicineHumansVDP::Medisinske Fag: 700ObesityTriglyceridesNutrition and Dieteticscardiorespiratory fitnessmedicine.diagnostic_testexercisebusiness.industryCardiorespiratory fitnessfat massMiddle Agedketogeniclipid profileCholesterolCardiovascular DiseasesLean body massBody CompositionFemalemedicine.symptombusinessLipid profilelow-carbohydrate high-fat-dietBody mass indexlcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population

2020

BACKGROUND AND AIMS Non-alcoholic fatty liver (NAFLD) is a major cause of liver disease worldwide leading also to a higher risk of cardiovascular events. We aimed to evaluate the impact of fatty liver and fibrosis on cardiovascular risk in a general population. METHODS Five hundred and forty-two subjects included in the community-based ABCD (Alimentazione, Benessere Cardiovascolare e Diabete) study were recruited. Steatosis (controlled attenuation parameter > 288 dB/m) and severe fibrosis (low risk, liver stiffness measurement [LSM] < 7.9 KPa with M probe and < 5.7 KPa with XL probe; intermediate risk, LSM 7.9-9.5 KPa with M probe and 5.7-9.2 KPa with XL probe; high risk, LSM ≥ 9.6 KPa with…

Adultcardiovascular riskmedicine.medical_specialtyPopulationGastroenterologyAsymptomatic03 medical and health sciencesLiver disease0302 clinical medicineatherosclerosiNon-alcoholic Fatty Liver DiseaseFibrosisInternal medicineNAFLDmedicineHumansSettore MED/49 - Scienze Tecniche Dietetiche Applicateeducationeducation.field_of_studySettore MED/12 - GastroenterologiaHepatologybusiness.industryFatty liverConfoundingGastroenterologyOdds ratiomedicine.diseasecarotidCardiovascular DiseasesHeart Disease Risk Factors030220 oncology & carcinogenesisABCD studyfatty liver disease030211 gastroenterology & hepatologySteatosismedicine.symptombusiness
researchProduct

Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients

1986

In 49 patients affected by PCO syndrome the serum levels of dehydroepiandroster-one-sulphate (DHEAs) were determined and correlated with the cfinical presentation and the endocrine pattern. Twenty-three patients (47%) had high DHEAs levels (h-DHEAs patients). They presented a milder clinical presentation (low incidence of amenorrhea) than PCO patients with normal DHEAs levels (n-DHEAs patients). In h-DHEAs patients the finding of a normal DHEAs. response to ACTH and of slightly increased 17OHP serum levels suggested that the elevation of serum DHEAs was not due to an adrenal enzymatic deficiency but to a tonic hyperstimulation of the adrenals. Two subgroups of h-DHEAs patients were identifi…

Adultendocrine systemmedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismDehydroepiandrosteroneEstroneAdrenocorticotropic hormoneBiologychemistry.chemical_compoundEndocrinologyDehydroepiandrosterone sulfateAdrenocorticotropic HormoneInternal medicinepolycyclic compoundsmedicineHumansEndocrine systemskin and connective tissue diseasesAmenorrheaThyrotropin-Releasing HormoneDehydroepiandrosterone SulfateAdrenal glandHyperandrogenismDehydroepiandrosteronemedicine.diseasePolycystic ovaryProlactinmedicine.anatomical_structureEndocrinologychemistryFemalehuman activitieshormones hormone substitutes and hormone antagonistsPolycystic Ovary SyndromeJournal of Endocrinological Investigation
researchProduct

Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome

1995

Objective To reevaluate the clinical significance of elevations of adrenal androgens in polycystic ovary syndrome (PCOS). Methods Thirty women with PCOS and ten ovulatory controls were evaluated. Serum dehydroepiandrosterone (DHEA) sulfate and 11β-hydroxyandrostenedione were measured before and after 3 and 6 months of GnRH agonist (GnRH-A) therapy. All controls and 15 women with PCOS received intravenous ACTH before and after GnRH-A therapy. Results Twenty-one (70%) of the women with PCOS had elevations of DHEA sulfate, and 16 (53%) had elevations in 11/3-hydroxyandrostenedione. Only two women with PCOS had normal values of both adrenal androgens. After GnRH-A therapy, only 11 subjects (37%…

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classDehydroepiandrosteroneOvaryPeptide hormonechemistry.chemical_compoundDehydroepiandrosterone sulfateAdrenocorticotropic HormoneInternal medicinepolycyclic compoundsmedicineHumansAndrostenedioneTriptorelin PamoateDehydroepiandrosterone Sulfatebusiness.industryAndrostenedioneObstetrics and GynecologyDehydroepiandrosteroneAndrogenPolycystic ovaryAndrogen secretionmedicine.anatomical_structureEndocrinologychemistryCase-Control StudiesFemaleLeuprolidebusinesshormones hormone substitutes and hormone antagonistsPolycystic Ovary SyndromeObstetrics &amp; Gynecology
researchProduct

Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial

2015

Objective: To report and discuss the multi-domain impact of elosulfase alfa, with focus on tertiary and composite endpoints, in the 24-week, randomized, double-blind, placebo-controlled phase 3 trial in patients with Morquio A syndrome (mucopolysaccharidosis IVA). Methods: Patients with Morquio A syndrome >= 5 aged years were randomized 1:1:1 to elosulfase alfa 2.0 mg/kg/week (qw; N = 58), elosulfase alfa 2.0 mg/kg/every other week (qow; N = 59), or placebo (N = 59) for 24 weeks. Primary and secondary efficacy measures were 6-minute walk test (6MWT; primary), 3-minute stair climb test (3-MSCT) and urinary keratan sulfate (KS). Safety was also evaluated. Tertiary efficacy measures included r…

Adultmedicine.medical_specialtyAdolescentIdursulfaseMucopolysaccharidosisEndocrinology Diabetes and MetabolismPlaceboBiochemistrylaw.inventionYoung Adultchemistry.chemical_compoundEndocrinologyDouble-Blind MethodRandomized controlled trialElosulfase alfalawSurveys and QuestionnairesInternal medicineActivities of Daily LivingmedicineGeneticsHumansEnzyme Replacement TherapyRespiratory functionYoung adultChildMolecular Biologybusiness.industryMucopolysaccharidosis IVMaximal Voluntary VentilationMiddle Agedmedicine.diseaseBody HeightChondroitinsulfatasesRespiratory Function TestsTreatment OutcomechemistryChild PreschoolPhysical therapyPopulation studybusinessmedicine.drugMolecular genetics and metabolism
researchProduct